April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) announced a 10-year strategic partnership agreement to support the hospital’s ambitious project JOY2030 renewal program. The program aims to transform the operations and facilities of Oulu University Hospital to meet the challenges of future specialist care for the approximately 750,000 inhabitants of northern Finland. Philips provides its latest image-guided therapy solutions and innovations to transform patient diagnosis and treatment, as well as maintenance, consulting and financing services.
The agreement will also serve as a catalyst for collaboration between the hospital and a team of Philips consultants specializing in providing services to drive healthcare transformation. Working closely with Oulu University Hospital, this team will identify unmet needs and help chart the way forward to maximize the benefits of the partnership and associated clinical research collaborations. Together, the organizations will drive efficiencies and innovations to help the hospital achieve the quadruple goal of better health outcomes, increased efficiency, and improved experiences for patients and staff.
Under the first phase of the agreement, Philips will provide 11 state-of-the-art interventional suites to support the hospital’s new Interventional Cardiology and Interventional Radiology departments. They will all be equipped with the latest version of Philips Image Guided Therapy System – Azurion with FlexArm – an advanced image-guided therapy platform that offers the latest innovations to help physicians improve treatment efficiency, workflow and outcomes, while providing a unique experience for patients and staff. Azurion, along with other integrated live 3D visualization and device guidance solutions from Philips, supports a wide range of minimally invasive procedures, from cardiac and vascular treatments to acute neuro and oncology treatments.
“Our goal is to build the smartest hospital in the world, able to meet the challenges of future specialist care and ensure the best possible treatments for the people we serve in northern Finland,” said Dr. Kari Ylitalo, head of the Heart Center at Oulu University Hospital. “We believe this long-term partnership with Philips, which provides us with the latest innovations and services in health technology, helps us deliver on this commitment.”
“Through our long-term strategic partnership with Oulu University Hospital and as a responsible business partner, we can optimally support them in realizing their vision for the future of healthcare,” said Mikko Vasama. , CEO of Philips Nordics. “With our expertise in cardiovascular care, our goal is to help clinicians better treat their patients by innovating existing image-guided therapy procedures and making entirely new ones possible. Thanks to this agreement, doctors at Oulu University Hospital will be able to provide their patients with the most advanced innovations for the treatment of heart and vascular diseases.
Examples of procedures that will take place in the new Interventional Cardiology and Interventional Radiology suites include catheter-based cardiac and vascular procedures to open clogged peripheral or coronary arteries, place implantable cardiac electronic devices, and treat cardiac arrhythmias, as well as acute neurological interventions (eg, stroke treatment) and cancer treatment procedures. For very complex procedures such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR), or combination therapies where open surgery and minimally invasive surgery may be involved, a Philips hybrid operating room – Azurion will also be installed. This integrates a surgical operating room and Azurion into a sterile environment for maximum flexibility.
To support multiple types of procedures, the interventional suites at Oulu University Hospital will be equipped with Philips Interventional Application Platform – IntraSight, a secure and fully integrated app-based platform that offers a comprehensive suite of clinically proven physiology, imaging and co-registration tools for image-guided procedures across the entire clinical workflow. intervention laboratory. It includes support for IVUS (intravascular ultrasound) catheters capable of imaging the interior of blood vessels and pressure wires capable of performing hemodynamic impact measurements such as FFR (fractional flow reserve) or iFR (ratio free of instantaneous wave). Other suites will be equipped with Philips Interventional Hemodynamic Systemwhich allows integration with the portable Philips IntelliVue X3 Patient Monitor to record continuous measurements such as ECG, blood pressure, oxygen saturation and respiratory rate before, during and after image-guided procedures.
Philips offers a comprehensive suite of solutions for the diagnosis and minimally invasive treatment of structural and peripheral vascular heart disease, which aim to remove the barriers associated with complex procedures by helping to deliver clinical confidence where it is needed most – at the processing point. These solutions help build clinical confidence, increase efficiency throughout the care journey, and improve the care experience for patients and staff.
The 10-year partnership agreement also includes an optional 10-year extension.